YBX3 and cholangiocarcinoma: The results (Figure 1A) showed that YBX3 was highly expressed across most cancer tissues compared with paracancerous tissues, and the expression level was relatively higher among CHOL (cholangiocarcinoma), COAD, KIRC (kidney renal clear cell carcinoma), KIRP (kidney renal papillary cell carcinoma), LUSC (lung squamous cell carcinoma), and THCA (thyroid carcinoma).